These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 3142091

  • 1. Altered fibrinolysis in DVT: influence of site of sampling.
    Han P, Koay ES, Tsakok M, Aw TC, Wong LY, Pradhan M.
    Thromb Haemost; 1988 Aug 30; 60(1):50-3. PubMed ID: 3142091
    [Abstract] [Full Text] [Related]

  • 2. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 3. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.
    Colucci M, Altomare DF, Chetta G, Triggiani R, Cavallo LG, Semeraro N.
    Thromb Haemost; 1988 Aug 30; 60(1):25-9. PubMed ID: 3142090
    [Abstract] [Full Text] [Related]

  • 4. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
    Grimaudo V, Bachmann F, Hauert J, Christe MA, Kruithof EK.
    Thromb Haemost; 1992 Apr 02; 67(4):397-401. PubMed ID: 1631786
    [Abstract] [Full Text] [Related]

  • 5. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.
    Juhan-Vague I, Valadier J, Alessi MC, Aillaud MF, Ansaldi J, Philip-Joet C, Holvoet P, Serradimigni A, Collen D.
    Thromb Haemost; 1987 Feb 03; 57(1):67-72. PubMed ID: 3109059
    [Abstract] [Full Text] [Related]

  • 6. Prospective double-arm study of fibrinolysis in surgical patients.
    Kosir MA, Schmittinger L, Barno-Winarski L, Duddella P, Pone M, Perales A, Lange P, Brish LK, McGee K, Beleski K, Pawlak J, Mammen E, Sajahan NP, Kozol RA.
    J Surg Res; 1998 Jan 03; 74(1):96-101. PubMed ID: 9536981
    [Abstract] [Full Text] [Related]

  • 7. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec 03; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 8. Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release.
    Levi M, Lensing AW, Büller HR, Prandoni P, Dooijewaard G, Cuppini S, ten Cate JW.
    Thromb Haemost; 1991 Oct 01; 66(4):426-9. PubMed ID: 1796391
    [Abstract] [Full Text] [Related]

  • 9. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
    Páramo JA, Alfaro MJ, Rocha E.
    Thromb Haemost; 1985 Oct 30; 54(3):713-6. PubMed ID: 3937269
    [Abstract] [Full Text] [Related]

  • 10. Diurnal variation of the fibrinolytic system.
    Grimaudo V, Hauert J, Bachmann F, Kruithof EK.
    Thromb Haemost; 1988 Jun 16; 59(3):495-9. PubMed ID: 3142085
    [Abstract] [Full Text] [Related]

  • 11. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW, Helmy A, Ludlam C, Webb DJ, Hayes PC, Newby DC.
    Thromb Res; 2008 Jun 16; 121(5):675-80. PubMed ID: 17870147
    [Abstract] [Full Text] [Related]

  • 12. Does low protein concentration of tissue-type plasminogen activator predict a low risk of spontaneous deep vein thrombosis?
    Gram J, Sidelmann J, Jespersen J.
    Thromb Haemost; 1995 Aug 16; 74(2):718-21. PubMed ID: 8585012
    [Abstract] [Full Text] [Related]

  • 13. Plasminogen activator inhibitor activity in bacterial infection.
    Páramo JA, Fernández Diaz FJ, Rocha E.
    Thromb Haemost; 1988 Jun 16; 59(3):451-4. PubMed ID: 3142082
    [Abstract] [Full Text] [Related]

  • 14. Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.
    Nguyen G, Horellou MH, Kruithof EK, Conard J, Samama MM.
    Blood; 1988 Aug 16; 72(2):601-5. PubMed ID: 3135860
    [Abstract] [Full Text] [Related]

  • 15. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).
    Kluft C, Jie AF, Rijken DC, Verheijen JH.
    Thromb Haemost; 1988 Apr 08; 59(2):329-32. PubMed ID: 3133814
    [Abstract] [Full Text] [Related]

  • 16. Fibrinolytic parameters in patients undergoing total hip replacement: relationship with the development of asymptomatic deep vein thrombosis and diagnostic usefulness of venous occlusion.
    Trotti R, Siragusa S, Rondanelli M, Chezzi L, Citterio A, Melzi d'Eril GV, Piovella F.
    Haematologica; 1997 Apr 08; 82(2):178-81. PubMed ID: 9175322
    [Abstract] [Full Text] [Related]

  • 17. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S.
    Dan Med Bull; 1993 Sep 08; 40(4):383-408. PubMed ID: 8222763
    [Abstract] [Full Text] [Related]

  • 18. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb 08; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 19. Endothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis.
    Francis RB, McGehee WG, Feinstein DI.
    Thromb Haemost; 1988 Jun 16; 59(3):412-4. PubMed ID: 3142079
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.